Neurobiological Technologies, Inc.
NTII · OTC
9/30/2009 | 6/30/2009 | 3/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Market Cap | $24,237 | $18,175 | $18,041 | $8,346 |
| - Cash | $9,583 | $8,230 | $6,009 | $6,914 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $14,654 | $9,945 | $12,032 | $1,432 |
| Revenue | $6,026 | $16,281 | $3,013 | $3,491 |
| % Growth | -63% | 440.4% | -13.7% | – |
| Gross Profit | $6,026 | $16,281 | $3,013 | $3,491 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $5,162 | $14,745 | -$259 | -$8,062 |
| % Margin | 85.7% | 90.6% | -8.6% | -230.9% |
| Net Income | $5,405 | $14,154 | -$431 | -$7,838 |
| % Margin | 89.7% | 86.9% | -14.3% | -224.5% |
| EPS Diluted | 0.2 | 0.525 | -0.02 | -0.29 |
| % Growth | -61.9% | 2,727.3% | 93.1% | – |
| Operating Cash Flow | $2,356 | -$5,087 | -$3,384 | -$4,946 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $2,356 | -$5,089 | -$3,382 | -$4,946 |